Contribute Try STAT+ Today

Three of the largest pharmaceutical wholesalers in the U.S. agreed to pay up to $1.1 billion to settle a lawsuit in which the state of New York claimed the companies contributed to the opioid crisis by failing to monitor suspicious shipments.

The deal – which involves AmerisourceBergen (ABC), Cardinal Health (CAH), and McKesson (MCK) – comes amid a trial that was already underway and as the companies also attempt to reach a deal to settle nationwide litigation brought by numerous states, cities, counties and Native American tribes. An agreement worth $21 billion is reportedly set to be announced this week.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment